Petri

Modern Synthesis is bringing life to new materials by working with bacteria to commercially develop a new class of biobased textiles which offer: (1) Performance without plastics or harsh chemicals: Materials which achieve strength and durability without petrochemical binders, harmful chemistries or toxic byproducts. (2) Aesthetics without animals: A versatile process that unlocks a wide range of looks, feels, and functions to meet designers’ seasonal needs with zero animal inputs. (3) Scale without starting from scratch: A process that leverages abundant raw materials and is designed to integrate with existing manufacturing infrastructure. Modern Synthesis’ technology leverages the intrinsic versatility of bacterial nanocellulose, which is nature’s finest and strongest form of cellulose. Their process not only displaces animal leathers, plastic-based synthetics and other nonwoven textiles, but also generate entirely new possibilities for designers.

Minus is a beanless coffee company which produces coffee.

New Equilibrium Biosciences provides a platform that reveals opportunities for structure-based design by learning biophysics with AI.

Yard Stick measures soil carbon. Scientists and farmers alike know that climate-friendly agricultural practices have the potential to remove atmospheric CO2 at gigaton/year scale. When these practices are adopted, more carbon is stored in soils, improving soil health and fighting climate change. But significant measurement challenges have held soil carbon efforts back - until now. By reducing the cost of soil carbon measurement by 90%+, Yard Stick will dramatically expand the opportunities for evidence-based regenerative practices to simultaneously improve ecosystem health, increase farmer income, and combat climate change.

Patients who experience complex high risk surgery or are expected to heal slowly are often managed with a wound drain. Current drain output monitoring practices are manual - nurses (in the hospital) and patients (at home) eyeball the color and volume. Inaccurate data means drains are usually installed longer than necessary and nurses and patients miss early onset of complications (infection, leaks, excessive bleeding, blockages). This results in longer lengths of stay and increased readmission rates. Medsix plans to sell a disposable sensor with predictive analytics that can be attached to any wound drain to automate monitoring. This will address the needs of patients (detect complications earlier; remove drains earlier; reduce overall recovery time), providers (improved clinical workflow and decision making; creating a standard for wound drain output) and payers (reduce length of stay; reduce readmission rates; increase reimbursements).

GALY produces agriculture from cells in a facility, not plants in the field

Matterworks is a biotech startup that combines metabolomics with AI to simulate the metabolic environment. The startup is enabling real-time insights into cellular biology to accelerate therapeutic research, development, and manufacturing with an AI-driven cloud platform for metabolomics. Matterworks was founded by Mimoun Cadosch Delmar and Jack Geremia in 2019.

New Equilibrium Biosciences provides a platform that reveals opportunities for structure-based design by learning biophysics with AI.